David Robinson, MD
Physical Medicine & Rehabilitation · Charlestown, MANPI 1235668567
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Bioventus LLC at 42.7% of the total. Reporting peaked in 2023 at $113 and has fallen 58.6% since, to $47 in 2024.
Across 6 payments — averaging $29.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bioventus LLC$75
- Endo USA, Inc.$24
- Endo Pharmaceuticals Inc.$23
- DJO, LLC$22
- Ferring Pharmaceuticals Inc.$16
- Neurocrine Biosciences, Inc.$15
What the payments were for
- Food & beverage$175100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bioventus LLC | 1 | $75 |
| Endo USA, Inc. | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| DJO, LLC | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
How this compares
$175 in reported general payments places this provider in the 60th percentile of 244 physical medicine & rehabilitation providers in Massachusetts.
See all physical medicine & rehabilitation providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 32 | $922 |
| Gabapentin | 15 | $182 |
| Meloxicam | 32 | $101 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Charlestown
- Sabrina PaganoniCharlestown$80K
- Moorice CaparoCharlestown$18K
- Michael ChiangCharlestown$3K
- Marc van de RijnCharlestown$1K
- Zachary BohartBurlington$633K
- Walter SussmanWellesley$50K
- Stephen KoelbelWeymouth$24K
- Didem InanogluBoston$13K
- Andrew DuarteWorcester$8K
- Jenna MeriggiHaverhill$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.